Context Capital Management, LLC Amryt Pharma PLC Transaction History

Context Capital Management, LLC

  • $330,000
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 12, 2021
SELL
$9.63 - $12.47 $49,710 - $64,370
-5,162 Reduced 6.66%
72,334 $871,000
Q1 2021

May 17, 2021
BUY
$13.04 - $14.75 $105,089 - $118,870
8,059 Added 11.61%
77,496 $1.08 Million
Q3 2020

Nov 16, 2020
BUY
$10.8 - $13.5 $749,919 - $937,399
69,437 New
69,437 $858,000

Others Institutions Holding AMYT

# of Institutions
5
Shares Held
142K
Call Options Held
0
Put Options Held
0
View Full List

About Amryt Pharma plc

AMYT Quotes by TradingView
  • Ticker AMYT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 64,177,000
  • Description
  • Amryt Pharma plc, a commercial-stage biopharmaceutical company, focuses on acquiring, developing, and commercializing various treatments to help improve the lives of patients with rare and orphan diseases. The company provides metreleptin, an adjunct to diet as replacement therapy to treat the complications of leptin deficiency in patients with ...
More about AMYT
Track This Portfolio

Track Context Capital Management, LLC Portfolio

Follow Context Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Context Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Context Capital Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email